NEWS

Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262 01/08/2024
EndeavorRx, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17
EndeavorRx, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17 12/18/2023
BeeKeeperAI Expands Privacy-Enhancing Innovation with New Patent, New Product, and New Advantages to Accelerate Responsible AI in Healthcare
BeeKeeperAI Expands Privacy-Enhancing Innovation with New Patent, New Product, and New Advantages to Accelerate Responsible AI in Healthcare 12/14/2023
Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders
Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders 12/13/2023
Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform
Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform 12/13/2023
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting
Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting 12/11/2023
Trial Library, oncology clinical trial technology company, announces release of provider decision support platform to advance access to trials in community oncology settings
Trial Library, oncology clinical trial technology company, announces release of provider decision support platform to advance access to trials in community oncology settings 12/08/2023
Exai Bio’s RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy
Exai Bio’s RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High Accuracy 12/08/2023
Autism’s Molecular Mechanisms Uncovered through Protein-Protein Interaction Network
Autism’s Molecular Mechanisms Uncovered through Protein-Protein Interaction Network 12/07/2023
MindRhythm Completes Enrollment in its Multicenter Prehospital Trial for Identifying Large Vessel Occlusion Stroke
MindRhythm Completes Enrollment in its Multicenter Prehospital Trial for Identifying Large Vessel Occlusion Stroke 12/04/2023
KSQ Therapeutics Announces FDA Clearance of IND Application for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy
KSQ Therapeutics Announces FDA Clearance of IND Application for KSQ-001EX, a CRISPR/Cas9 Engineered Tumor Infiltrating Lymphocyte (eTIL®) Therapy 12/04/2023
AskBio Announces First Patient Randomized in Phase 1 Trial of Gene Therapy for Multiple System Atrophy-Parkinsonian
AskBio Announces First Patient Randomized in Phase 1 Trial of Gene Therapy for Multiple System Atrophy-Parkinsonian 11/21/2023
Autobahn Labs Announces Key Licensing Milestones in Alliances with Early University Partners
Autobahn Labs Announces Key Licensing Milestones in Alliances with Early University Partners 11/14/2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin
AbbVie Exercises Exclusive Right to Acquire Mitokinin 11/14/2023
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis 11/13/2023